Wuhan Zy Pharmaceutical Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is POSACONAZOLE FORM 1, with a corresponding US DMF Number 29228.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 12, 2016, and payment made on February 03, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II